CRWV (CRWV) insider plans Rule 144 common share sale on NASDAQ

Rhea-AI Filing Summary

A Rule 144 notice reports a planned sale of 32,455 common shares of the issuer through Morgan Stanley Smith Barney LLC, with an aggregate market value of 2,839,163.40 and 386,401,201 shares outstanding, to be sold around 01/14/2026 on NASDAQ.

The shares to be sold are common stock originally acquired as founder shares from the issuer on 11/13/2017, in the same amount of 32,455, with payment dated 11/13/2017 and noted as N/A for the nature of payment.

The filing also lists prior three‑month sales of the issuer’s common stock for the account of the same overall selling group, including 10b5‑1 sales for MICHAEL INTRATOR of 61,386 shares on 01/06/2026 for gross proceeds of 4,674,746.47, and 10b5‑1 sales for OMNADORA CAPITAL LLC of 50,000 shares on several dates with multi‑million dollar proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32455	2839163.40	386401201	01/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			32455	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	32455	2124981.39
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	50000	3273735.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	32455	2495279.96
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	50000	3844215.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	32455	2424654.63
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	50000	3735410.00
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/14/2025	75000	5946097.50
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	32455	3698951.52
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	50000	5698585.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/22/2025	32455	3848449.75
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/22/2025	50000	5928688.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRWV Form 144 filing disclose?

The Form 144 notice discloses an intended sale of 32,455 common shares of the issuer’s stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/14/2026.

How many CRWV shares are planned to be sold and at what value?

The filing reports that 32,455 common shares are proposed to be sold, with an aggregate market value of 2,839,163.40 as shown in the securities information table.

How and when were the CRWV shares being sold under Rule 144 originally acquired?

The shares covered by the notice are listed as Common acquired on 11/13/2017 as Founders Shares from the issuer, in the amount of 32,455, with the date of payment also shown as 11/13/2017 and the nature of payment marked as N/A.

What does the Form 144 say about CRWV shares outstanding?

In the securities information section, the number of shares or other units outstanding is shown as 386,401,201 common shares, providing context for the issuer’s total equity base.

Which broker and exchange are involved in the planned CRWV share sale?

The notice identifies the broker as Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, and lists NASDAQ as the securities exchange where the common shares are to be sold.

What recent CRWV share sales by related parties are listed in the past 3 months?

The past three months table lists multiple common stock sales, including 10b5‑1 sales for MICHAEL INTRATOR of 61,386 shares on 01/06/2026 for 4,674,746.47 in gross proceeds, and 10b5‑1 sales for OMNADORA CAPITAL LLC of 50,000 shares on several dates with gross proceeds in the multi‑million range.

What representation does the seller make in the CRWV Form 144 notice?

The signature section states that the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and references additional representations if relying on a Rule 10b5‑1 trading plan.